XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Restructuring and impairment charges
3 Months Ended
Mar. 27, 2022
Restructuring and Related Activities [Abstract]  
Restructuring and impairment charges Restructuring and impairment chargesWe have ongoing restructuring initiatives consisting of a plan, initiated in connection with the Respiratory business divestiture described in Note 4, designed to separate the manufacturing operations to be transferred to Medline from those that will remain with Teleflex (the “Respiratory divestiture plan”), and plans related to the relocation of manufacturing operations to existing lower-cost locations and related workforce reductions (referred to as the 2019 and 2018 Footprint realignment plans). The following tables provide a summary of our cost estimates and other information associated with these plans:
Respiratory divestiture plan2019 Footprint realignment plan2018 Footprint realignment plan
Plan expense estimates:(Dollars in millions)
Termination benefits
$5 to $8
$14 to $15
$60 to $65
Other costs (1)
— to —
2 to 2
3 to 4
Restructuring charges
5 to 8
16 to 17
63 to 69
Restructuring related charges (2)
19 to 22
38 to 43
47 to 59
Total restructuring and restructuring related charges
$24 to $30
$54 to $60
$110 to $128
Other plan estimates:
Expected cash outlays
$24 to $30
$48 to $54
$99 to $122
Expected capital expenditures
$22 to $28
$31 to $33
$15 to $16
Other plan information:
Period initiatedMay 2021February 2019May 2018
Estimated period of substantial completion202320222022
Aggregate restructuring charges$2.8$14.9$62.7
Restructuring reserve:
Balance as of March 27, 2022$2.7$2.2$42.9
Restructuring related charges incurred:
Three Months Ended March 27, 2022$2.0$1.1$2.3
Aggregate restructuring related charges$5.3$35.3$29.7
(1)Includes facility closure, employee relocation, equipment relocation and outplacement costs.
(2)Restructuring related charges represent costs that are directly related to the plans and principally constitute costs to transfer manufacturing operations to the existing lower-cost locations, project management costs and accelerated depreciation. The 2018 Footprint realignment plan also includes a charge associated with our exit from the facilities that is expected to be imposed by the taxing authority in the affected jurisdiction. Excluding this tax charge, substantially all of the restructuring related charges are expected to be recognized within cost of goods sold.
In 2014, we initiated a restructuring plan involving the consolidation of operations and a related reduction in workforce at certain facilities, in addition to the relocation of manufacturing operations from certain higher-cost locations to existing lower-cost locations (the "2014 Footprint realignment plan”). The plan is substantially complete and as a result, we expect future restructuring expenses associated with the plan, if any, to be immaterial.
Restructuring and impairment charges recognized for the three months ended March 27, 2022 and March 28, 2021 consisted of the following:
Three Months Ended March 27, 2022
Termination benefits
Other costs (1)
Total
Respiratory divestiture plan$106 $14 $120 
2019 Footprint realignment plan(670)24 (646)
2018 Footprint realignment plan158 62 220 
Other restructuring plans (2)
1,132 82 1,214 
Restructuring charges726 182 908 
Asset impairment charges— 1,497 1,497 
Restructuring and impairment charges$726 $1,679 $2,405 
Three Months Ended March 28, 2021
Termination benefits
Other costs (1)
Total
2021 Restructuring plan$6,760 $— $6,760 
2019 Footprint realignment plan341 105 446 
2018 Footprint realignment plan267 45 312 
Other restructuring plans (3)
(166)646 480 
Restructuring charges$7,202 $796 $7,998 
(1) Other costs include facility closure, contract termination and other exit costs.
(2) Includes activity primarily related to a restructuring plan initiated in the first quarter of 2022 that is designed to relocate manufacturing operations at certain of our facilities, the 2021 Restructuring plan and the 2014 Footprint realignment plan.
(3) Includes the plan initiated during the third quarter of 2019 as well as the 2016 and 2014 Footprint realignment plans.